Sunday, November 6, 2011

There must be a pony in here somewhere...

Before mandatory reporting and pay-for-performance, and before zero became the only acceptable infection rate, it was OK to have somewhat subjective, imperfect definitions for healthcare associated infections. No longer!

Never fear…HICPAC has working groups now grappling with three different definitions: for CLABSI, VAP and SSI (full disclosure: I’m a member of these working groups). Here are just a few desired attributes of any newly-modified HAI definition:

  • Must have excellent performance characteristics (most importantly, nearly 100% specificity) when compared with gold standards (note: gold standards do not yet exist).
  • Must consist of only objective measures that can be collected by all NHSN participating hospitals, and that are amenable to electronic reporting and easy validation.
  • Must demonstrate excellent concordance with clinical definitions of infection, so as not to lose credibility with frontline clinicians (note: because of the subjectivity of clinical definitions, this attribute is not consistent with the attribute above).
  • Must not be subject to “gaming”, even by the most creative hospitals (note: even supposedly “objective” measures, like culture and antibiotic use data, are subject to practice changes in response to pressure to reduce HAI rates).
  • Must not result in public or political perception that modifications were made in an attempt to lower HAI rates (i.e. “define our way to zero”).

So, keeping these in mind, feel free to submit any suggested changes to current definitions, in the comments section!

Friday, November 4, 2011

The Affect Heuristic

Source: XKCD.com
We've discussed conflicts of interest and bias frequently, particularly in regards to guidelines.  Bob Centor has a nice post today that discusses the affect heuristic and how it might impact clinical guidelines.

The affect heuristic suggests that a good feeling or emotion towards a situation (i.e., positive affect) would result in a person having a lower risk perception and higher benefit perception than supported by an unbiased look at the data. I think this is closely related to confirmation bias, which we have written about frequently, as well.

His recommendation for selection of guideline panels - choose strong methodologists who are non-experts - is one worth pondering.

Wednesday, November 2, 2011

Disgust and Infection Prevention

That's disgusting! (source: wikipedia)
Just came across this great article in the journal Philosophical Transactions for the Royal Society B, titled "Why Disgust Matters." In the paper Valerie Curtis of the London School of Hygiene and Tropical Medicine argues that the human feeling of "disgust" evolved to motivate infectious disease avoidance. She suggests that a better understanding of disgust could be harnessed to combat the behavioural causes of infectious and chronic disease such as diarrheal disease, influenza and even smoking.

You could imagine that more knowledge around "disgust" or what motivates good behavior (covering your face when you sneeze or washing your hands) could greatly improve infection prevention in hospitals.

Curtis V, Phil. Trans. R. Soc. B 12 December 2011 vol. 366 no. 1583 3478-3490 (abstract) (full text)

Related BBC Article by Health Reporter Philippa Roxby

Tuesday, November 1, 2011

Conflicting Results in Clinical Trials: the APC Example

Dan posted last week on activated protein C (Xigris) being withdrawn from the market.  David Rind (Evidence in Medicine blog) has posted his thoughts on what might have been behind the initial positive study in 2001 and subsequent negative studies.  It is worth a read.

David Rind: APC and Conflicting Trials (10/29/2011)

Odds and ends







Here are a few odds and ends that I've been mulling over--some related to infection prevention, some tangentially related, and some, well not at all.


  • A new paper in the International Journal of Obesity looks to see whether response to influenza vaccine is impacted by obesity. This is important since during the H1N1 pandemic obesity was found to be a risk factor for morbidity and mortality. Interestingly, in this study of nearly 500 participants the investigators found that antibody production is not affected by BMI, but as BMI increases there is a significant decrease in antibody detected at 12 months. The implications of this paper could be huge given the increasing prevalence of obesity in the US.
  • I just read Steven Berk's recently published book, Anatomy of a Kidnapping, on a quick trip to Vermont. Berk is an infectious diseases physician and medical school dean, who was kidnapped at gunpoint from his home in 2005. He writes that equanimity helped him to stay cool through the entire ordeal. Though this may have saved his life, I think it robbed some of the emotion from his prose, and I was left with little connection to what should have been a very compelling story. And if I were not on a plane without anything else to read, I would have closed the book for sure when he articulates his view that individuals should be allowed to purchase and own assault weapons.
  • Coldplay's new album, Mylo Xyloto, is simply amazing. I can't quit listening to it. It's already setting records for the rate (there's a tie to epidemiology!) of digital downloads it's receiving.
  • Dick Wenzel, the most famous hospital epidemiologist since Semmelweis, has in his "retirement"  published a novel and danced the tango for charity. This week he will debut in VCU's production of the musical Grease. He plays the DJ, Vince Fontaine. He still has a day job, too--this week he's attending on the Transplant ID Service. 

Monday, October 31, 2011

Happy Halloween!

Maggie and Alicia
 
Nothing better than infection prevention related Halloween costumes.  I'm still trying to imagine Mike dressed as a flu vaccine, but its a bit difficult.  Anyway, here in Iowa City Maggie dressed as a collection of hospital pathogens clinging to Alicia, a contaminated textile.  Good times.

Sunday, October 30, 2011

Science Friday: Influenza Vaccine Debate

Mike Osterholm, PhD MPH
Earlier this week, Mike posted his thoughts on the recent Lancet ID review of influenza vaccine efficacy.  This week's Science Friday featured a "debate" between Mike Osterholm, one of the authors, and Bill Schaffner. The discussion covers several important topics including the utility of influenza vaccine in seniors.

Click here to listen to the mp3 audio (full hour, but the vaccine discussion is first up)

Source: Science Friday (NPR, Talk of the Nation)

OSHA! OSHA! OSHA!

  In many parts of the country, as rates of COVID-19 are declining and vaccination coverage is increasing (albeit with substantial variati...